📷 Image: Flickr (CC)
Health
RMSCL to Probe Rajasthan Cancer Drug Supply After Black‑Market Leak
✍️ Amar Ujala · Jaipur
🗓 20 Aug 2026, 07:35 AM
👁 2
The Rajasthan Medical Services Commission (RMSCL) will examine the entire supply chain of government‑provided cancer medication after it was found in the black market, questioning hospitals and medical colleges about their record‑keeping.
Rajasthan's Medical Services Commission (RMSCL) announced an inquiry into how government‑issued cancer drugs, intended for hospital use, entered the illegal market. The probe will trace the drug's journey from procurement to distribution, focusing on the role of hospitals and affiliated medical colleges in maintaining usage records.
According to the investigation notice, the responsibility for safe handling and documentation of the medicines lies with the receiving hospitals or medical colleges. Authorities have therefore summoned the concerned medical college for an explanation of any lapses that may have allowed the drugs to be diverted.
The RMSCL aims to map the entire supply network across the state to identify weak points and prevent future leaks. Findings are expected to inform stricter monitoring protocols and possible legal action against any parties found culpable.
The move follows growing concerns about the availability of essential oncology drugs on the black market, which threatens patient safety and undermines public health initiatives.
Officials have not disclosed the specific quantities involved, but have emphasized that the investigation will be thorough and transparent, with results to be shared with the health department and the public.
According to the investigation notice, the responsibility for safe handling and documentation of the medicines lies with the receiving hospitals or medical colleges. Authorities have therefore summoned the concerned medical college for an explanation of any lapses that may have allowed the drugs to be diverted.
The RMSCL aims to map the entire supply network across the state to identify weak points and prevent future leaks. Findings are expected to inform stricter monitoring protocols and possible legal action against any parties found culpable.
The move follows growing concerns about the availability of essential oncology drugs on the black market, which threatens patient safety and undermines public health initiatives.
Officials have not disclosed the specific quantities involved, but have emphasized that the investigation will be thorough and transparent, with results to be shared with the health department and the public.